In short
Progesterone, Micronised is a hormone medication being studied in clinical trials for its potential to improve outcomes in various fertility treatments. These trials aim to determine the effectiveness and safety of different formulations and dosages of progesterone in supporting pregnancy and live birth rates for couples struggling with infertility. The studies focus on its use in treatments such as intrauterine insemination (IUI), in vitro fertilization (IVF), and frozen embryo transfer (FET).
At a glance
- Drug Name
- Progesterone, Micronised
- Main Uses in Trials
- Luteal phase support in IUI, IVF, and FET treatments
- Administration
- Vaginal capsules (various dosages)
- Primary Outcomes
- Live birth rates, ongoing pregnancy rates
- Secondary Outcomes
- Embryo quality, implantation rates, clinical pregnancy rates
- Target Population
- Women with unexplained infertility or undergoing fertility treatments
- Safety Assessment
- Side effects, pregnancy complications, neonatal outcomes
- Additional Measures
- Cost-effectiveness, quality of life impact
What is Micronized Progesterone?
Micronized progesterone is a form of the hormone progesterone that has been processed to create very small particles. This micronization process makes the hormone easier for your body to absorb and use. Progesterone is a naturally occurring hormone in the female body, playing a crucial role in the menstrual cycle and maintaining pregnancy.
Medical Uses
Micronized progesterone is primarily used in the field of reproductive medicine. Its main applications include:
- Assisted Reproductive Technology (ART): It's used to support the luteal phase (the period after ovulation) during fertility treatments.
- Intrauterine Insemination (IUI): Some studies are investigating its use in IUI treatments.
- In Vitro Fertilization (IVF): It's commonly used in IVF procedures, particularly in frozen embryo transfer cycles.
- Unexplained Infertility: Research is being conducted on its potential benefits for couples with unexplained infertility.
Administration
Micronized progesterone can be administered in different ways:
- Vaginal Use: The most common form is vaginal capsules or gel. This method allows for direct absorption by the uterus.
- Oral Use: In some cases, it may be taken orally, although this is less common in fertility treatments.
The dosage and duration of treatment can vary depending on the specific medical condition and treatment protocol. For example, in some IVF protocols, patients might use 200mg three times daily or 400mg twice daily.
Effectiveness
The effectiveness of micronized progesterone in fertility treatments is an active area of research. Some key points include:
- In IVF treatments, progesterone supplementation is considered standard care and has been shown to improve pregnancy outcomes.
- For IUI treatments, research is ongoing to determine if progesterone supplementation can increase live birth rates.
- In frozen embryo transfer cycles, progesterone is crucial for preparing the uterus for embryo implantation.
Side Effects and Safety
Micronized progesterone is generally considered safe for use in fertility treatments. However, like all medications, it can have side effects. Common side effects may include:
- Drowsiness
- Dizziness
- Abdominal pain
- Nausea
- Breast tenderness
It's important to note that extensive safety data is available from its use in IVF treatments. Both short-term and long-term assessments of offspring health have not revealed any significant risks associated with progesterone use in reproductive medicine.
Ongoing Research
Several clinical trials are currently underway to further investigate the use of micronized progesterone in various fertility treatments:
- The LUMO study is examining whether progesterone support can improve live birth rates in couples undergoing IUI with mild ovarian stimulation.
- Another study is comparing different formulations and dosages of vaginal micronized progesterone in frozen embryo transfer cycles.
- Researchers are also investigating the impact of progesterone levels on pregnancy outcomes in frozen embryo transfer cycles.
These ongoing studies aim to optimize the use of micronized progesterone in various fertility treatments, potentially improving success rates and patient outcomes.